Gastroenterology
Volume 133, Issue 5 , Pages 1718-1721 , November 2007

Hepatitis B: Explosion of New Knowledge

  • Emmet B. Keeffe

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Emmet B. Keeffe, MD, Stanford University Medical Center, 750 Welch Road, Suite #210, Palo Alto, California 94304-1509. fax: (650) 498-5692.

References 

  1. Ganen D, Prince AM. Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med. 2004;350:1118–1129
  2. Yim HJ, Lok ASF. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006;43:S173–S181
  3. Keeffe EB, Dieterich DT, Han SB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4:936–962
  4. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–539
  5. Lok ASF. Navigating the maze of hepatitis B treatments. Gastroenterology. 2007;132:1586–1594
  6. McQuillan GM, Coleman PJ, Kruszon-Moran D, et al. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89:14–18
  7. US Census Bureau State and County Quickfacts: 01 February 2005. Available at: http://quickfacts.census.gov/qfd/states/00000.html. Accessed September 16, 2007.
  8. Phase III study evaluating Gilead’s Viread for the treatment of chronic hepatitis B virus meets primary endpoint [press release on the Internet]. Updated June 6, 2007. Available at: www.gilead.com/pr_1012569. Accessed September 16, 2007.
  9. Second phase III study evaluating Gilead’s Viread for the treatment of chronic hepatitis B virus meets primary endpoint [press release on the Internet]. Updated June 25, 2007. Available at: www.gilead.com/pr_1018988. Accessed September 16, 2007.
  10. Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521–1531
  11. Arora G, Keeffe EB. Chronic hepatitis B with advanced hepatic fibrosis or cirrhosis: impact of antiviral therapy. Rev Gastroenterol Disord. 2007;7:63–73
  12. Ghany M, Liang TJ. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology. 2007;132:1574–1585
  13. Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452–1457
  14. Chu CM, Liaw YF. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology. 2007;133:1458–1465
  15. Gish RG, Lok AS, Chang TT, et al. Entecavir therapy up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gastroenterology. 2007;133:1437–1444
  16. Lampertico P, Viganò M, Manenti E, et al. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology. 2007;133:1445–1451
  17. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73
  18. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678–686
  19. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005;23:2409–2423
  20. Liu CH, Kao JH. Hepatitis B virus genotypes: what should the clinician know?. Current Hepatitis Reports. 2007;6:17–23
  21. Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354:1001–1010
  22. Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354:1011–1020
  23. Colonno RJ, Rose RE, Pokornowski K, et al. Four year assessment of ETV resistance in nucleoside-naive and lamivudine refractory patients. J Hepatol. 2007;46:S294;[abstract 781]

PII: S0016-5085(07)01758-1

doi: 10.1053/j.gastro.2007.09.048

Gastroenterology
Volume 133, Issue 5 , Pages 1718-1721 , November 2007

Article Tools